O-046 CT Screening for lung cancer: The relationship of disease stageto tumor size

Lung Cancer ◽  
2005 ◽  
Vol 49 ◽  
pp. S18
Author(s):  
C. Henschke ◽  
S. Sone ◽  
S. Markowitz ◽  
M. Tockman ◽  
D. Shaham ◽  
...  
2009 ◽  
Vol 27 (15_suppl) ◽  
pp. 1540-1540 ◽  
Author(s):  
N. Seki ◽  
K. Eguchi ◽  
M. Kaneko ◽  
H. Ohmatsu ◽  
R. Kakinuma ◽  
...  

1540 Background: We have investigated the individualized benefit of CT screening as Anti-Lung Cancer Association projects (presented at ASCO 2006–2008). However, there has not been enough information about the relationship of lung cancer stage to tumor size in repeated CT screening. Therefore, we evaluated the stage-size relationship of these asymptomatic lung cancer cases diagnosed by long-term repeated screening with low-dose helical CT. Methods: Among 2,120 participants (mean age 63 years, 87% male, and 83% smoker) at baseline screening, 1,877 underwent semiannually repeated screening from 1993 to 2004. Nineteen (0.90%) prevalence cancers and 57 (0.32%) incidence cancers were detected. Within categories of tumor size, the distribution of pathological stage, histology, lymph node status, and distant metastases was determined. Results: Pathological stage has a strong relationship to tumor size at baseline screening (spearman r = 0.63, p = 0.013) and repeated screening (r = 0.65, p < 0.001). In the analysis of all 76 cases, lymph node status (r = 0.59, p < 0.001) and distant metastases (r = 0.55, p = 0.005) have also a strong relationship to tumor size. The percentages of cases with no metastases (N0M0) were 100% (0/21), 89% (17/19), 62% (8/13), 83% (10/12), 50% (4/8), and 33% (1/3) for the categories 10 mm or less, 11 mm to 15 mm, 16 mm to 20 mm, 21 mm to 30 mm, 31 mm to 40 mm, and 41 mm or greater, respectively. Histology for the categories 15 mm or less was localized bronchioloalveolar carcinoma in 13 cases, adenocarcinoma with mixed subtype in 11 cases, invasive adenocarcinoma in five cases, other non-small cell carcinoma in 10 cases, and small cell carcinoma in one case. Accumulated 10-year hazard ratio of above histology was 2.4, 2.5, 2.6, 4.1, and 0.7. In multivariate analyses, pathological stage was related to only tumor size (standardized regression coefficient beta = 0.59, p < 0.001) whereas histology was related to tumor size (beta = 0.43, p < 0.001) and smoking index (beta = 0.28, p = 0.016). Conclusions: These results provide direct evidence of a stage-size relationship in long-term repeated CT screening for lung cancer. Furthermore, early detection of lung cancer of 15 mm or less in diameter leads to the detection of early-stage (N0M0) lung cancer in repeated CT screening. No significant financial relationships to disclose.


2012 ◽  
Vol 11 (3) ◽  
pp. 604-615 ◽  
Author(s):  
Medhi Wangpaichitr ◽  
Elizabeth J. Sullivan ◽  
George Theodoropoulos ◽  
Chunjing Wu ◽  
Min You ◽  
...  

2002 ◽  
Vol 18 (3) ◽  
pp. 150-159 ◽  
Author(s):  
Mary E. Cooley ◽  
Thomas H. Short ◽  
Helene J. Moriarty

Knowledge of the patterns of symptom distress in adults receiving treatment for lung cancer is an important first step in developing interventions that can potentially lessen symptom distress. The purposes of this secondary analysis were to describe the changes in patterns of symptom distress over time in adults receiving treatment for lung cancer, and to examine the relationship of selected demographic and clinical characteristics to symptom distress. Complete data were available for 117 patients. The patterns of symptom distress in adults receiving treatment for lung cancer varied between treatment groups and over time. Symptom distress scores were moderate to high on entry into the study, indicating that symptom management in newly diagnosed lung cancer patients is essential and should begin early in the course of illness. Moreover, clinical interventions should be tailored to the type of treatment. Various demographic and clinical variables were weak and inconsistent predictors of symptom distress, underscoring the importance of examining the role of psychosocial factors in mediating symptom distress.


CHEST Journal ◽  
2006 ◽  
Vol 130 (4) ◽  
pp. 231S
Author(s):  
Mika Uchiyama ◽  
Koji Kawaguchi ◽  
Toshiki Okasaka ◽  
Shimon Ito ◽  
Naohito Sato ◽  
...  

1987 ◽  
Vol 35 (3) ◽  
pp. 147-156 ◽  
Author(s):  
Clifton F. Mountain ◽  
John M. Lukeman ◽  
Samuel P. Hammar ◽  
Dean W. Chamberlain ◽  
Walter F. Coulson ◽  
...  

2016 ◽  
Vol 1 (2) ◽  
Author(s):  
Xinying Xue ◽  
Yuxia Liu ◽  
Mingming Meng ◽  
Guigen Teng ◽  
Xuefeng Zang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document